Latest Massachusetts News | Page 6

TRISH to study spaceflight effects on genome and nervous system on Axiom Space’s Ax-3 Mission
SETH MACFARLANE’S TED BROUGHT TO LIFE BY MELBOURNE VFX STUDIO FRAMESTORE IN AUSTRALIA
Mission to wake up Moriori language
CSRankings: Würzburg Computer Scientists at Top
Boosting beta cells to treat Type 2 diabetes
Baylor Researchers highlight benefits of sharing human brain data
Can AI help boost accessibility? These researchers tested it for themselves
AstraZeneca announces collaboration and investment agreement with Cellectis to accelerate cell therapy and genomic medicine ambitions
Four Synergy Grants for five Max Planck researchers
Rockwell Automation and Microsoft Expand Partnership to Leverage Generative AI Capabilities for Enhanced Productivity and Faster Time-to-Market
South Australian researchers join forces with global defence consortium
UniSA and Uni of Adelaide join forces with global defence consortium
Soliris approved in China for the treatment of adults with neuromyelitis optica spectrum disorder (NMOSD)
Closing in on elusive neutrino
Alexion data at 9th Joint ECTRIMS-ACTRIMS Meeting (MSMilan2023) showcase impact of C5 inhibition in NMOSD
Braiding Indigenous knowledge and science
Gene Editing in Human Stem Cells and Neurons Reveals Links Between Genome Organization and Autism
TRISH calls for postdoctoral proposals for fellowship program
Stacking Order and Strain Boosts Second-Harmonic Generation with 2D Janus Hetero-bilayers
Linguistic luminary, Sir Patu Hohepa’s legacy
NSF funds internet-connected ocean observatory through 2028
Cornell to lead carbon-cutting effort in aluminum recycling
Alexion completes purchase and licence agreement for early-stage rare disease gene therapy portfolio from Pfizer
Tuning the Chern Number in the Nitrogen-Vacancy Center in Diamond
A tax on menthol cigarettes would work better than statewide bans, UW study finds
Update on US regulatory review of Ultomiris in NMOSD
AI systems have learned how to deceive humans. What does that mean for our future?
Strong in Shanghai Ranking
Soliris approved in Japan for paediatric patients with generalised myasthenia gravis (gMG)
Police Involvement May Hamstring Overdose Outreach Efforts
Using broad race categories in medicine hides true health risks
Mosquitoes: Fact and Fiction on Bite Prevention
Carbon dioxide – not water – triggers explosive volcanoes
Unveiling the Anomalous Dynamics of Non-collinear Antiferromagnets
Delivering world-leading mathematics in South Australian public schools
Alexion, AstraZeneca Rare Disease, enters agreement with Pfizer to acquire a portfolio of preclinical rare disease gene therapies
Soliris approved in the EU for children and adolescents with refractory generalised myasthenia gravis (gMG)
TRISH selects 2023 class of space health postdoctoral fellows
Space-ready menstrual cup giant leap for womankind
UNSW Sydney rockets into the global top 20 in latest QS Rankings
Researchers make a quantum computing leap with a magnetic twist
Do Children Inherit Parents’ Stressful Experiences?
IATA Launches World Sustainability Symposium
Soliris recommended for approval in the EU by CHMP for children and adolescents with refractory generalised myasthenia gravis (gMG)
MIT’s global innovation initiative hones in on WA
Wildfire smoke downwind affects health, wealth and mortality
Award-winning therapy brings light into darkness
Hungry gold miners created Victoria’s Murray cod fisheries – and we’re still dealing with the consequences